Welcome to the new home of G&L Scientific. Same great company, great new look.

Select your language

Paving the way for successful FDA meetings

Paving the way for successful FDA meetings

Client:

Small Bio-pharmaceutical company.

Client Challenge:

Our client was developing a novel platform for stimulating immune responses (killer T-cells) for the treatment of solid and blood cancers either as monotherapy or in combination with other treatments.

G&L Solution:

Within this engagement we reviewed the available early-stage clinical and regulatory data and further development plans for the compound in ovarian cancer.

Led the cross-functional team in development and submission of Agency questions and Briefing Books for FDA and Health Canada Meetings (introduction of novel platform technology, review of clinical studies completed to date, development plans and potential opportunity for enhanced Agency support).

Prepared the team for the meetings in slides development and preparation of responses to potential Regulatory questions during meetings and debriefing post-meeting/preparation of meeting minutes.

Publishing and eCTD submission of other ongoing activities.

Outcome:

Following our guidance, the client had successful FDA and Health Canada Meetings, gaining the endorsement of their planned, ongoing development for the product, with useful guidance for future development.

Start your journey with G&L

Discover what G&L can do for you today.

Related Case Studies

Find out more about the solutions we provide to meet the biggest challenges in global healthcare.

Ready to reach your potential?

Discover how G&L can help you do business better

Contact Us